Pharmaceutical Technology18h
Overcoming regulatory challenges in sterile manufacturing
Evolving regulations in sterile manufacturing requires innovation, market knowledge, and investment. How can drug ...
Dealbreaker on MSN11d
Pharma Firms Mallinckrodt and Endo Agree to Merge in $6.7B Cash and Stock Deal
When the deal closes, Endo will become a wholly owned subsidiary of Mallinckrodt. The combined company will take on a ...
MyChesCo on MSN9d
Noramco Group Invests $25 Million to Expand Sterile Injectable Manufacturing
The Noramco Group has announced a $25 million investment to expand its Halo Pharma facility in Whippany, New Jersey, by ...
Mallinckrodt to take over Endo in deal valued at $6.7 billion
Ireland’s Mallinckrodt will buy U.S. drugmaker Endo in a cash-and-stock deal valued at $6.7 billion. The companies said ...
Fierce Pharma6d
CDMO Delpharm gets cash infusion from Canada to help modernize former Sandoz injectables plant
After getting its hands on a massive Quebecois manufacturing plant from Sandoz in 2022, French CDMO Delpharm is making good ...
Endo agrees to merge with Mallinckrodt in deal valued at almost $7B
Malvern-based Endo has found a merger partner, agreeing to combine with another troubled pharmaceutical firm in a deal valued ...
Mallinckrodt to merge with another drugmaker, Endo, in nearly $7B deal
Mallinckrodt, the Irish pharmaceutical company with its U.S. headquarters in Hazelwood, has agreed to merge with drug maker ...
Wall Street Journal12d
Mallinckrodt, Endo Merger to Create Diversified Pharmaceuticals Firm
The companies said Thursday they reached a definitive agreement to bring together their generic pharmaceuticals businesses and Endo’s sterile injectables business, which they aim to separate ...